伊马替尼依赖的Bcr-Abl阳性慢性髓性白血病细胞酪氨酸磷酸化谱分析。 - Suppr

Suppr

超能文献

Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells.

作者信息

Preisinger C, Schwarz J P, Bleijerveld O B, Corradini E, Müller P J, Anderson K I, Kolch W, Scholten A, Heck A J R

出版信息

Leukemia. 2013 Mar;27(3):743-6. doi: 10.1038/leu.2012.243. Epub 2012 Aug 27.

DOI:10.1038/leu.2012.243

PMID:22976128

Abstract

摘要

相似文献

Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells.伊马替尼依赖的Bcr-Abl阳性慢性髓性白血病细胞酪氨酸磷酸化谱分析。

Leukemia. 2013 Mar;27(3):743-6. doi: 10.1038/leu.2012.243. Epub 2012 Aug 27.

PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.新型酪氨酸激酶抑制剂PD166326在慢性髓性白血病小鼠模型中具有比甲磺酸伊马替尼更强的抗白血病活性。

Blood. 2005 May 15;105(10):3995-4003. doi: 10.1182/blood-2004-09-3534. Epub 2005 Jan 18.

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.与组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸（SAHA）联合治疗可增强伊马替尼诱导的Bcr-Abl阳性人类急性白血病细胞凋亡。

Blood. 2003 Apr 15;101(8):3236-9. doi: 10.1182/blood-2002-08-2675. Epub 2002 Nov 21.

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.Bcr-Abl表达水平决定慢性髓性白血病对甲磺酸伊马替尼耐药的发展速度。

Cancer Res. 2005 Oct 1;65(19):8912-9. doi: 10.1158/0008-5472.CAN-05-0076.

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.在一例接受伊马替尼治疗的慢性髓性白血病患者中含有扩增的bcr-abl融合基因的双微体

Eur J Haematol. 2003 Apr;70(4):235-9. doi: 10.1034/j.1600-0609.2003.00046.x.

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration.甲磺酸伊马替尼治疗后慢性粒细胞白血病急变期的BCR/ABL扩增

Cancer Genet Cytogenet. 2002 Nov;139(1):30-3. doi: 10.1016/s0165-4608(02)00615-5.

Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.雷公藤红素诱导急变期慢性髓性白血病细胞包括静止的 CD34+原始祖细胞死亡，而不依赖于细胞对伊马替尼的反应。

Mol Cancer Ther. 2009 Sep;8(9):2509-16. doi: 10.1158/1535-7163.MCT-09-0386. Epub 2009 Sep 1.

Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis.缩肽（FK228）优先诱导表达BCR/ABL的细胞系以及处于急变期的慢性粒细胞白血病患者的细胞发生凋亡。

Stem Cells Dev. 2007 Jun;16(3):503-14. doi: 10.1089/scd.2007.9994.

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.FTY720，一种治疗急变期慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的新选择。

J Clin Invest. 2007 Sep;117(9):2408-21. doi: 10.1172/JCI31095.

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.伊马替尼可诱导处于髓系原始细胞危象的慢性髓性白血病患者产生血液学和细胞遗传学反应：一项II期研究的结果。

Blood. 2002 May 15;99(10):3530-9. doi: 10.1182/blood.v99.10.3530.

引用本文的文献

The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner.巨HECT E3泛素连接酶HERC1在髓系相关疾病中表达异常，且是一种新型的BCR-ABL1结合伴侣。

Cancers (Basel). 2021 Jan 19;13(2):341. doi: 10.3390/cancers13020341.

Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid.一种用于定量检测人脑脊液中酪氨酸39磷酸化α-和β-突触核蛋白的新方法的开发。

Clin Proteomics. 2020 May 4;17:13. doi: 10.1186/s12014-020-09277-8. eCollection 2020.

IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells.IgG 非依赖性 FcεRI 和 FcγRIIB 的共聚集导致鼠骨髓来源肥大细胞中 FcγRIIB 的 LYN 和 SHIP1 依赖性酪氨酸磷酸化。

Front Immunol. 2018 Aug 27;9:1937. doi: 10.3389/fimmu.2018.01937. eCollection 2018.

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase.致癌性 Bcr-Abl 酪氨酸激酶的 DH 和 PH 结构域的结构与功能剖析。

Nat Commun. 2017 Dec 13;8(1):2101. doi: 10.1038/s41467-017-02313-6.

Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.患者来源异种移植瘤的磷酸化酪氨酸定量分析确定了儿童白血病的治疗靶点。

Cancer Res. 2016 May;76(9):2766-2777. doi: 10.1158/0008-5472.CAN-15-2786. Epub 2016 Mar 9.

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.阿昔替尼和索拉非尼对酪氨酸激酶抑制剂耐药的慢性髓性白血病细胞有效。

Cell Commun Signal. 2016 Feb 24;14:6. doi: 10.1186/s12964-016-0129-y.

Phosphoproteomics-mediated identification of Fer kinase as a target of mutant Shp2 in Noonan and LEOPARD syndrome.磷酸化蛋白质组学介导的Fer激酶鉴定：作为努南综合征和豹皮综合征中突变型Shp2的一个靶点

PLoS One. 2014 Sep 3;9(9):e106682. doi: 10.1371/journal.pone.0106682. eCollection 2014.

Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics.开发一种 5 重 SILAC 方法，用于定量检测酪氨酸磷酸化动力学。

Mol Cell Proteomics. 2013 Nov;12(11):3339-49. doi: 10.1074/mcp.O113.027342. Epub 2013 Jul 23.

Semi-supervised prediction of SH2-peptide interactions from imbalanced high-throughput data.基于不平衡高通量数据的 SH2 肽相互作用的半监督预测。

PLoS One. 2013 May 17;8(5):e62732. doi: 10.1371/journal.pone.0062732. Print 2013.

Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells.伊马替尼和达沙替尼治疗慢性髓性白血病细胞中 Gab2 信号复合物的改变。

Cell Commun Signal. 2013 Apr 22;11(1):30. doi: 10.1186/1478-811X-11-30.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验